Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Reference64 articles.
1. Black DM, Rosen CJ. Postmenopausal osteoporosis. N Engl J Med. 2016;374(21):2096–7.
2. Eastell R, O’Neill TW, Hofbauer LC, et al. Postmenopausal osteoporosis. Nat Rev Dis Prim. 2016;2:16069.
3. Amgen Europe B. V. Prolia 60 mg solution for injection in pre-filled syringe: EU summary of product characteristics. 2018. http://www.ema.europa.eu . Accessed 22 Jan 2018.
4. Amgen Manufacturing Limited. Prolia® (denosumab) injection, for subcutaneous use: US prescribing information 2017. http://pi.amgen.com/united_states/prolia/prolia_pi.pdf . Accessed 22 Jan 2018.
5. Kostenuik PJ, Nguyen HQ, McCabe J, et al. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. J Bone Miner Res. 2009;24(2):182–95.
Cited by
115 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献